Document is current

Any future updates will be listed below

Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors

Crossref DOI link: https://doi.org/10.1186/s40425-019-0789-4

Published Online: 2019-11-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark